This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.
Patients aged 18-80 years
Primary and secondary lymphedema of the upper or lower extremity
International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
Proficiency in English language
Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.
Patients who present for consultation of their lymphedema and who meet eligibility criteria will be offered the option of enrolling in this study at the time of their initial consultation.
Case-control
Prospective
Quality of Life Assessments
BehavioralUpper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.
Quality of Life
Questionnaire to assess quality of life changes
Click on the lead sponsor to view all of their trials.
